복제 및 돌연변이 유발 시장 규모, 점유율, 성장 분석 : 제품 및 서비스별, 방법별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Cloning And Mutagenesis Market size was valued at USD 2.8 Billion in 2024 and is poised to grow from USD 3.32 Billion in 2025 to USD 12.8 Billion by 2033, growing at a CAGR of 18.4% during the forecast period (2026-2033).

The cloning and mutagenesis market is experiencing significant growth driven by the increasing demand for precise genetic tools in pharmaceutical research and agricultural biotechnology. This sector encompasses various instruments, reagent kits, and services essential for gene cloning, targeted mutational studies, and vector development, all pivotal for drug discovery and enhancing crop quality. Advancements such as CRISPR technology and high-throughput cloning have reduced costs, making these tools widely accessible, especially among academia and biopharma firms relying on outsourcing. The rising popularity of contract research and integrated services empowers smaller biotech companies to utilize complex capabilities economically. Additionally, AI is revolutionizing this industry by automating workflows and enhancing design precision, fostering a collaborative environment that promotes efficiency and scalability in R&D processes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cloning And Mutagenesis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cloning And Mutagenesis Market Segments Analysis

The global cloning and mutagenesis market is segmented by product & service, technique, application, end user and region. Based on product & service, the market is segmented into Cloning Kits, Mutagenesis Kits, Enzymes & Reagents, Competent Cells, Vectors & Plasmids, Synthetic DNA & Gene Fragments, Custom Cloning & Mutagenesis Services, Software & Bioinformatics Tools and Others. Based on technique, the market is segmented into Restriction Enzyme-Based Cloning, PCR Cloning, TOPO Cloning, Gibson Assembly, Golden Gate Assembly, Site-Directed Mutagenesis, Random Mutagenesis, CRISPR-Based Genome Editing and Others. Based on application, the market is segmented into Gene Expression Studies, Protein Engineering, Antibody Engineering, Drug Discovery & Development, Synthetic Biology, Functional Genomics, Cell Line Development, Agricultural Biotechnology, Industrial Biotechnology and Others. Based on end user, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations (CROs), Clinical & Diagnostic Laboratories, Agricultural & Environmental Research Organizations and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cloning And Mutagenesis Market

Advancements in cloning vectors, genome editing technologies, delivery mechanisms, and high-fidelity enzymes have significantly enhanced researchers' capabilities while reducing technical barriers, allowing more teams to experiment with complex protocols. As the quality of tools improves, overall reproducibility and efficiency increase, leading to greater investment in instruments and consumables. Furthermore, as protocols become more accessible, simplifying their implementation for non-specialists, the demand for specialized reagents and service-based solutions rises. This not only facilitates market growth by penetrating diverse academic, industrial, and clinical research sectors but also fosters innovation and encourages the development of novel applications across various biologically related disciplines worldwide.

Restraints in the Global Cloning And Mutagenesis Market

The Global Cloning and Mutagenesis market faces several challenges stemming from stringent regulatory frameworks, varied approval processes across different regions, and elevated biosafety standards. These factors can hinder cloning and mutagenesis initiatives by introducing delays and increasing the administrative burden, which may discourage potential adopters and prolong procurement cycles. Compliance costs can escalate for laboratories and suppliers, while uncertainty surrounding the acceptability of certain applications adds to the complexity. Furthermore, the necessity for extensive paperwork, documentation, and validation procedures can restrict swift market entry, delay the launch of innovative products, and lead stakeholders to exercise caution when exploring advanced techniques, despite their promising scientific potential and prospective long-term benefits.

Market Trends of the Global Cloning And Mutagenesis Market

The Global Cloning and Mutagenesis market is experiencing a notable shift towards platform integration and automation, enabling enhanced efficiency and reproducibility across research and industrial laboratories. By consolidating cloning and mutagenesis workflows into interoperable systems, the automation of routine molecular procedures significantly reduces hands-on time and daily variability, fostering higher throughput and standardized outcomes. As vendors increasingly provide end-to-end systems that incorporate design software, automated liquid handling, and sequence verification, projects benefit from a streamlined approach. This trend facilitates faster iterations, lowers operational complexities, and promotes the adoption of advanced techniques, ultimately leading to more predictable results and optimized resource utilization.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Cloning And Mutagenesis Market Size by Product & Service & CAGR (2026-2033)

• Market Overview
• Cloning Kits
• Mutagenesis Kits
• Enzymes & Reagents
• Competent Cells
• Vectors & Plasmids
• Synthetic DNA & Gene Fragments
• Custom Cloning & Mutagenesis Services
• Software & Bioinformatics Tools
• Others

Global Cloning And Mutagenesis Market Size by Technique & CAGR (2026-2033)

• Market Overview
• Restriction Enzyme-Based Cloning
• PCR Cloning
• TOPO Cloning
• Gibson Assembly
• Golden Gate Assembly
• Site-Directed Mutagenesis
• Random Mutagenesis
• CRISPR-Based Genome Editing
• Others

Global Cloning And Mutagenesis Market Size by Application & CAGR (2026-2033)

• Market Overview
• Gene Expression Studies
• Protein Engineering
• Antibody Engineering
• Drug Discovery & Development
• Synthetic Biology
• Functional Genomics
• Cell Line Development
• Agricultural Biotechnology
• Industrial Biotechnology
• Others

Global Cloning And Mutagenesis Market Size by End User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations (CROs)
• Clinical & Diagnostic Laboratories
• Agricultural & Environmental Research Organizations
• Others

Global Cloning And Mutagenesis Market Size & CAGR (2026-2033)

• North America (Product & Service, Technique, Application, End User)
  • US
  • Canada
• Europe (Product & Service, Technique, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Service, Technique, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Service, Technique, Application, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Service, Technique, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genscript Biotech Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integrated DNA Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synbio Technologies LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lucigen Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OriGene Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Addgene, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Biogene
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enzynomics Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jena Bioscience GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioneer Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations